The dynamics of ET levels as well as of their prostate densities may associate with metabolic disorders and increasing BMI so that all these changes impact by promoting cancer induction and progression in an environment where epithelial cells are poorly differentiated for not being exposed to appropriate levels of testosterone; furthermore, lower PSA amounts are produced by the specific cells [5, 9, 35–37]. This evidence concerns the gene KLK3 and metabolic disease.